Arcadia Biosciences (RKDA) Shares Outstanding (Weighted Average) (2014 - 2025)

Arcadia Biosciences has reported Shares Outstanding (Weighted Average) for 12 years, with the latest figure at $1.4 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) changed 0.35% year-over-year to $1.4 million; the trailing twelve-month figure through Dec 2025 stood at $1.4 million (changed 0.35% YoY), and the FY2025 full-year result was $1.4 million, changed 0.35% from the prior year.
• Shares Outstanding (Weighted Average) for Q4 2025 stood at $1.4 million, roughly flat from $1.4 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $21.7 million in Q2 2021, with the low at $195885.0 in Q2 2025.
• Historically, Shares Outstanding (Weighted Average) has averaged $3.8 million across 5 years, with a median of $739102.5 in 2022.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) plunged 97.45% — and 2024, when it soared 298.68%.
• Arcadia Biosciences' Shares Outstanding (Weighted Average) stood at $287757.0 in 2021, then surged by 108.3% to $599389.0 in 2022, then plunged by 42.95% to $341957.0 in 2023, then soared by 298.68% to $1.4 million in 2024, then grew by 0.35% to $1.4 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $1.4 million (Q4 2025), $1.4 million (Q3 2025), and $195885.0 (Q2 2025), per Business Quant data.